top of page
IHPtherapeutics_edited.png
About

About

IHP Therapeutics is developing IHP-102 for the treatment of acute vaso-occlusive crisis in sickle cell disease. Empowering individuals with sickle cell, IHP-102 aims to be the first self-administered rescue therapeutic, moving care to the home setting and avoiding costly and ill-equipped healthcare systems.
 

Team

Our Team

psd.jpg

Rinko Ghosh, MS, MBA
President and CEO

Jocelyn_Jackson_Q4736_HI_RES.jpg

Jocelyn Jackson
CFO

Nate Bachtell Image.jpg
Web picture Jun16.jpeg

Peggy McLaughlin

VP of Clinical Operations

Board of Directors

psd.jpg

Rinko Ghosh, MS, MBA

Vlad.jpg

Vlad Hogenhuis, MD, MBA

John_Paderi_Q5979_HI_RES.jpg

John Paderi, PhD

Our Team

psd.jpg

Rinko Ghosh, MS, MBA
President and CEO

John_Paderi_Q5979_HI_RES.jpg

John Paderi, PhD
CSO
 

IMG_4566.jpeg

Gabriel Njikang, PhD
CMC

Web picture Jun16.jpeg

Peggy McLaughlin
Clin. Ops. Advisor

Jocelyn_Jackson_Q4736_HI_RES.jpg

Jocelyn Jackson
CFO

Kate2_Full Size.jpg

Kate Stuart, PhD
 VP of Program Management

Nate IHP Image 2.png

Nathan Bachtell, MD
Clinical Advisor

j.jpg

Robert Van Gorp
Strategic Sourcing

Board of Directors

psd.jpg

Rinko Ghosh, MS, MBA

Vlad.jpg

Vlad Hogenhuis, MD, MBA

John_Paderi_Q5979_HI_RES.jpg

John Paderi, PhD

Clinical and Scientific Advisors

Science
sickle blood image.jpg

Science 

IHP-102 is a novel dual P-selectin and complement inhibitor, which are two key mechanisms of vaso-occlusion in sickle cell disease. During acute vaso-occlusive pain crises, blockade of these mechanisms shows strong promise for disease-modifying effect and could reduce both pain symptoms and the tissue and organ damage cause by this devastating condition.

IHP Pipeline

Pipeline

Contact:

IHP Therapeutics

930 Brittan Avenue

 San Carlos, CA 94070

info@ihptherapeutics.com

IHP Therapeutics has recently been made aware of a growing number of email scams targeting job candidates in the biotech industry. IHP exclusively uses @ihptherapeutics.com email addresses for any and all communication. We do not ask candidates to purchase anything, nor do we ask for any sensitive information via email. If a person claiming to represent IHP with an alternative email domain reaches out to you regarding a job posting, please report it to our team by emailing info@ihptherapeutics.com. Thank you.

bottom of page